title: Breast cancer drugs should be offered to healthy but high risk women, US panel concludes.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008875:Middle Aged; D017698:Postmenopause; D017410:Practice Guidelines as Topic; D020849:Raloxifene Hydrochloride / Q000008:administration & dosage*; D012306:Risk; D013629:Tamoxifen / Q000008:administration & dosage*; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D013629:Tamoxifen; D020849:Raloxifene Hydrochloride